February 3, 2020 — The U.S. Food and Drug Administration (FDA) has approved a the CATALYST trial designed to assess Abbott's Amplatzer Amulet left atrial appendage (LAA) occluder for people with atrial fibrillation (AF or AFib). 

February 3, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of January 2020. This is based on the website’s 268,078 pageviews for the month:

1. New Guidelines for Stress Echocardiography in Ischemic Heart Disease

January 31, 2020 — A new study from the Smidt Heart Institute at Cedars-Sinai and other centers nationwide shows that patients who underwent a minimally invasive transcatheter aortic valve replacement (TAVR), had similar key five-year clinical outcomes of death and stroke as patients who had traditional open-heart surgery to replace the valve. 

January 31, 2020 – The U.S. Food and Drug Administration (FDA) has given Medtronic approval to proceed with an investigational device exemption (IDE) trial to evaluate the safety and effectiveness of the PulseSelect Pulsed Field Ablation (PFA) System. This new technology that uses pulsed electric fields to treat atrial fibrillation (Afib or AF). 

January 29, 2020 – Nuance Communications Inc. introduced Nuance Cardiovascular CAPD, a new computer-assisted physician documentation (CAPD) solution designed to help cardiologists improve the quality of complex documentation and the accuracy of reimbursement for cardiac catheterization procedures.

January 31, 2020 – The Society for Vascular Surgery (SVS) and Society of Thoracic Surgeons (STS) released new reporting standards to ensure patients with Type B aortic dissections (TBAD) receive appropriate treatment and care.

Abbott Tendyne TMVR, TMVI system received European CE mark clearance in January 2020. The Abbott Tendyne transcatheter mitral valve replacement (TMVR) system uses an anchor attached to the apex of the heart with a whether line attached to the valve. This helps to keep the valve anchored in the mitral annulus and prevent embolization. This anchor system was used because, unlike the aortic valve, the mitral valve has a very thin landing zone to secure the valve. Prevents LVOT obstruction.

January 30, 2020 — The Abbott Tendyne Transcatheter Mitral Valve Implantation (TMVI) system received European CE mark this week. It is the first transcatheter mitral valve replacement (TMVR) technology to gain commercial clearance in the world. It addresses a critical need to eliminate mitral regurgitation when surgery or mitral repair is not an option in high-risk surgical patients. 

Cardiology Summit 2020

 

Also called the International Conference on Cardiology & Cardiovascular Diseases.

Heart Team Summit

The Heart Team Summit joins Cardiology and Cardiac Surgery faculty at Washington University, St. Louis, Ascension/St. Vincent in Indianapolis, and Northwestern University. This educational initiative was developed to provide a forum for discussing and presenting laboratory and clinical research concerning the care of patients through case based coronary and structural heart intervention cases. This initiative strives to help those treating cardiology patients with the latest updates.

The movement from paper electrocardiogram (ECG) review to electronic ECG management systems in the past decade has helped improve efficiency and complete the patient electronic medical record (EMR). Current ECG management systems now offer improved workflow efficiencies, greater interoperability and integration into...

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now